← Back to Search

Behavioural Intervention

Virtual Reality Therapy for Anxiety

N/A
Recruiting
Led By Tsai Jack, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Awards & highlights

Study Summary

This trial will test if a VR intervention can help reduce anxiety symptoms in college students, by having them undergo six VR sessions over the course of three weeks.

Who is the study for?
This trial is for students at The University of Texas Health Science Center School of Public Health San Antonio campus who can speak English and have a mild level of anxiety. Students with photosensitive epilepsy, vision or balance issues, or those currently in therapy for anxiety or who were treated within the last year cannot participate.Check my eligibility
What is being tested?
The study is testing 'gameChange', a virtual reality therapy program, to see if it helps reduce anxiety symptoms over six sessions within three weeks. It also looks at how this VR treatment might improve students' confidence in their academic abilities.See study design
What are the potential side effects?
Since this intervention involves virtual reality, some participants may experience temporary discomfort like dizziness, nausea, or headaches during the VR sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Psychomotor agitation such as Fidgeting
Change in Psychomotor agitation such as Rubbing hands/neck/head
Change in Psychomotor agitation such as pacing
+8 more
Secondary outcome measures
Change in acceptability as assessed by the rating on a short questionnaire
Change in perceived presence in the virtual environment (as indicated by continuous score on the Igroup Presence Questionnaire (IPQ)
Change in self-reported academic performance as assessed by the Motivated Strategies for Learning Questionnaire (MSLQ)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: gameChangeExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
914 Previous Clinical Trials
324,272 Total Patients Enrolled
1 Trials studying Anxiety
20 Patients Enrolled for Anxiety
Tsai Jack, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

gameChange (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05319509 — N/A
Anxiety Research Study Groups: gameChange
Anxiety Clinical Trial 2023: gameChange Highlights & Side Effects. Trial Name: NCT05319509 — N/A
gameChange (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05319509 — N/A
~55 spots leftby Apr 2027